Company Quick10K Filing
Akari Therapeutics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$1.72 1,581 $2,719
20-F 2018-12-31 Annual: 2018-12-31
20-F 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31

Akari Therapeutics Financials

-

AKTX Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Arrowhead Pharmaceuticals (ARWR) 2,850 337 111 137 0 46 50 2,661
Medicines (MDCO) 2,822 956 918 -3 -5 -218 -178 2,497
Ultragenyx Pharmaceutical (RARE) 3,447 959 139 70 68 -371 -359 3,313
Mirati Therapeutics (MRTX) 4,037 501 29 5 0 -142 -142 3,785
Alkermes (ALKS) 3,373 1,752 661 1,067 887 -183 -71 3,455
Nektar Therapeutics (NKTR) 5,930 2,100 542 119 73 -423 -394 5,844
Taro Pharmaceutical Industries (TARO) 4,109 2,135 224 0 0 0 0 3,541
Akari Therapeutics (AKTX) 2,577 8 5 0 0 -3 -3 2,571
Arena Pharmaceuticals (ARNA) 2,948 1,285 84 814 0 593 712 2,748
PTC Therapeutics (PTCT) 2,489 1,292 803 0 0 -213 -187 2,509
Global Blood Therapeutics (GBT) 3,233 769 65 0 0 -199 -191 2,892
Myokardia (MYOK) 2,131 616 32 22 0 -107 -107 1,685
Amicus Therapeutics (FOLD) 3,054 918 318 0 113 -442 -415 2,831
Agios Pharmaceuticals (AGIO) 2,918 784 251 102 100 -389 -389 2,294
Redhill Biopharma (RDHL) 1,521 62 11 0 0 0 0 1,513
Reata Pharmaceuticals (RETA) 2,552 300 334 29 0 -120 -109 2,351
Xencor (XNCR) 2,268 685 77 172 0 49 54 2,236
Emergent Biosolutions (EBS) 2,477 2,321 1,332 878 353 -18 67 3,152
Uniqure (QURE) 2,824 253 121 3 0 -103 -95 2,673
Cambrex (CBM) 1,517 1,516 839 575 199 54 119 1,952

Balance Sheet ($MM)2013-12-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-12-312018-12-31
Cash864379696134286
Accounts Receivable
Inventory
PP&E0000000000
Assets864379706346298
Accounts Payable1101441222
Long-Term Debt
Liabilities222238211712125
Stockholders' Equity653141494634173
Income Statement ($MM)2013-12-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-12-312018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D20121
SG&A11322
Tax-10000
Net Income-2-2-496-3
Cash Flow ($MM)2013-12-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-12-312018-12-31
Cash Operating-2-15-7-7
Cash Investing001-0-0
Cash Financing0072-3